Clover Health (CLOV) | Financial Analysis & Statements
Clover Health Investments Corp. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
487.7M
Gross Profit
74.2M
15.22%
Operating Income
-49.3M
-10.11%
Net Income
-49.3M
-10.11%
Balance Sheet Metrics
Total Assets
541.0M
Total Liabilities
232.3M
Shareholders Equity
308.7M
Debt to Equity
0.75
Cash Flow Metrics
Operating Cash Flow
-60.9M
Free Cash Flow
-68.7M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Clover Health Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.9B | 1.4B | 2.0B | 3.5B | 1.5B |
| Cost of Goods Sold | 1.6B | 1.0B | 1.8B | 3.5B | 1.6B |
| Gross Profit | 355.9M | 364.8M | 257.3M | 22.7M | -79.2M |
| Gross Margin % | 18.5% | 26.6% | 12.7% | 0.7% | -5.4% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 439.7M | 408.9M | 444.7M | 486.6M | 445.7M |
| Other Operating Expenses | - | - | -7.2M | -93.4M | 110.8M |
| Total Operating Expenses | 439.7M | 408.9M | 437.5M | 393.2M | 556.6M |
| Operating Income | -85.5M | -45.5M | -182.7M | -371.6M | -637.0M |
| Operating Margin % | -4.4% | -3.3% | -9.0% | -10.7% | -43.3% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 0 | 0 | 7.0K | 1.4M | 16.9M |
| Other Non-Operating Income | -20.0K | -805.0K | -30.7M | 33.4M | 66.1M |
| Pre-tax Income | -85.5M | -46.3M | -213.4M | -339.6M | -587.8M |
| Income Tax | - | - | - | - | - |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -85.5M | -43.0M | -213.4M | -339.6M | -587.8M |
| Net Margin % | -4.4% | -3.1% | -10.5% | -9.8% | -39.9% |
| Key Metrics | |||||
| EBITDA | -83.8M | -44.1M | -180.2M | -370.5M | -635.7M |
| EPS (Basic) | $-0.17 | $-0.08 | $-0.44 | $-0.71 | $-1.25 |
| EPS (Diluted) | $-0.17 | $-0.08 | $-0.44 | $-0.71 | $-1.25 |
| Basic Shares Outstanding | 511967146 | 490018730 | 482176127 | 476244262 | 470852394 |
| Diluted Shares Outstanding | 511967146 | 490018730 | 482176127 | 476244262 | 470852394 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Clover Health Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 78.3M | 194.5M | 122.9M | 103.8M | 300.0M |
| Short-term Investments | 42.0M | 27.0M | 119.8M | 231.0M | 315.3M |
| Accounts Receivable | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other Current Assets | 10.6M | 15.6M | 1.4M | 4.0M | 2.5M |
| Total Current Assets | 307.9M | 343.1M | 428.0M | 625.0M | 752.5M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 113.0K | 113.0K | 3.5M | 4.3M | 5.5M |
| Goodwill | 3.0M | 3.0M | 3.0M | 31.7M | 4.2M |
| Intangible Assets | 3.0M | 3.0M | 3.0M | 8.3M | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 24.1M | 13.3M | 10.2M | 15.7M | 10.4M |
| Total Non-Current Assets | 233.2M | 237.6M | 142.7M | 183.6M | 198.3M |
| Total Assets | 541.0M | 580.7M | 570.7M | 808.6M | 950.8M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 36.2M | 34.6M | 37.2M | 32.4M | 28.1M |
| Short-term Debt | - | - | 1.7M | 1.8M | 3.1M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 3.3M | 3.5M | 16.6M | 74.3M | 37.0M |
| Total Current Liabilities | 208.8M | 213.5M | 261.1M | 431.5M | 372.6M |
| Non-Current Liabilities | |||||
| Long-term Debt | - | - | 3.0M | 4.0M | 24.8M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 23.5M | 26.1M | 20.2M | 16.2M | 14.1M |
| Total Non-Current Liabilities | 23.5M | 26.1M | 23.2M | 20.2M | 38.9M |
| Total Liabilities | 232.3M | 239.6M | 284.3M | 451.7M | 411.5M |
| Equity | |||||
| Common Stock | 52.0K | 50.0K | 49.0K | 46.0K | 46.0K |
| Retained Earnings | -2.3B | -2.2B | -2.2B | -1.9B | -1.6B |
| Treasury Stock | 86.2M | 31.0M | 12.7M | 6.5M | 147.0K |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 308.7M | 341.1M | 286.4M | 356.9M | 539.3M |
| Key Metrics | |||||
| Total Debt | 0 | 0 | 4.7M | 5.9M | 27.8M |
| Working Capital | 99.0M | 129.6M | 166.9M | 193.5M | 379.9M |
Balance Sheet Composition
Clover Health Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -85.5M | -43.0M | -213.4M | -339.6M | -587.8M |
| Depreciation & Amortization | 1.7M | 1.3M | 2.5M | 1.2M | 1.2M |
| Stock-Based Compensation | 103.7M | 114.3M | 140.9M | 164.3M | 163.7M |
| Working Capital Changes | -76.1M | 13.6M | 50.4M | -99.9M | 39.9M |
| Operating Cash Flow | -57.9M | 83.1M | -23.6M | -275.4M | -368.9M |
| Investing Activities | |||||
| Capital Expenditures | -2.0M | -1.6M | -584.0K | -4.5M | -723.0K |
| Acquisitions | - | 0 | 0 | -16.4M | 0 |
| Investment Purchases | -205.1M | -201.2M | -175.6M | -369.4M | -876.3M |
| Investment Sales | 211.2M | 203.4M | 316.2M | 485.4M | 441.5M |
| Investing Cash Flow | 4.1M | 565.0K | 140.0M | 95.1M | -435.4M |
| Financing Activities | |||||
| Share Repurchases | -55.2M | -18.3M | -6.2M | -6.4M | -147.0K |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | - | 0 | 0 |
| Debt Repayment | - | - | 0 | 0 | -30.9M |
| Financing Cash Flow | -53.4M | -17.4M | -33.9M | 77.5M | 925.1M |
| Free Cash Flow | -69.0M | 33.3M | -116.5M | -290.8M | -283.0M |
| Net Change in Cash | -107.2M | 66.3M | 82.6M | -102.8M | 120.7M |
Cash Flow Trend
Clover Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-14.09
Forward P/E
27.78
Price to Book
4.20
Price to Sales
0.68
PEG Ratio
-0.09
Profitability Ratios
Profit Margin
-4.45%
Operating Margin
-10.11%
Return on Equity
-26.33%
Return on Assets
-9.53%
Financial Health
Current Ratio
1.47
Debt to Equity
0.00
Beta
2.25
Per Share Data
EPS (TTM)
$-0.17
Book Value per Share
$0.60
Revenue per Share
$3.76
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| CLOV | 1.3B | -14.09 | 4.20 | -26.33% | -4.45% | 0.00 |
| UnitedHealth | 322.3B | 26.81 | 3.42 | 12.18% | 2.68% | 73.98 |
| CVS Health | 101.1B | 55.65 | 1.31 | 2.29% | 0.44% | 106.06 |
| Progyny | 1.4B | 27.18 | 2.83 | 12.48% | 4.54% | 5.37 |
| Elevance Health | 76.4B | 13.19 | 1.67 | 13.25% | 2.84% | 74.39 |
| Cigna | 72.7B | 12.61 | 1.77 | 15.13% | 2.17% | 75.14 |
Financial data is updated regularly. All figures are in the company's reporting currency.






